The grants will enable CDC to work in collaboration with partners to advance the implementation of meningitis and rotavirus vaccines, ensuring global disease protection.

To show the health impact of low-cost, Indian-made rotavirus vaccines in high burden, low-income countries of Africa and Asia.

To provide travel support for onsite technical assistance to countries conducting various rotavirus studies.

To support the chemistry, manufacturing and control (CMC) and preclinical development of an inactivated rotavirus vaccine.

To help implement the CDC Foundation programs and activities supporting the Targeted Country Assistance portion of the 2022-2025 Partners’ Engagement Framework.

To support the production and qualification of inactivated rotavirus vaccine clinical material.